BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24636516)

  • 1. The role of hypocortisolism in chronic fatigue syndrome.
    Nijhof SL; Rutten JM; Uiterwaal CS; Bleijenberg G; Kimpen JL; Putte EM
    Psychoneuroendocrinology; 2014 Apr; 42():199-206. PubMed ID: 24636516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK; Cleare AJ; Wessely S; Wood PJ; Taylor NF
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome.
    Roerink ME; Roerink SHPP; Skoluda N; van der Schaaf ME; Hermus ARMM; van der Meer JWM; Knoop H; Nater UM
    Horm Behav; 2018 Jul; 103():1-6. PubMed ID: 29807037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH; Sharpe M; Clements A; Dowling B; Hawton KE; Cowen PJ
    Biol Psychiatry; 1998 Feb; 43(3):236-7. PubMed ID: 9494707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
    J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary cortisol response to awakening in chronic fatigue syndrome.
    Roberts AD; Wessely S; Chalder T; Papadopoulos A; Cleare AJ
    Br J Psychiatry; 2004 Feb; 184():136-41. PubMed ID: 14754825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction.
    Heim C; Nater UM; Maloney E; Boneva R; Jones JF; Reeves WC
    Arch Gen Psychiatry; 2009 Jan; 66(1):72-80. PubMed ID: 19124690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls.
    Nater UM; Maloney E; Boneva RS; Gurbaxani BM; Lin JM; Jones JF; Reeves WC; Heim C
    J Clin Endocrinol Metab; 2008 Mar; 93(3):703-9. PubMed ID: 18160468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK; Taylor NF; Peters TJ; Wessely S; Cleare AJ
    Psychosom Med; 2006; 68(4):578-82. PubMed ID: 16868267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol output in adolescents with chronic fatigue syndrome: pilot study on the comparison with healthy adolescents and change after cognitive behavioural guided self-help treatment.
    Rimes KA; Papadopoulos AS; Cleare AJ; Chalder T
    J Psychosom Res; 2014 Nov; 77(5):409-14. PubMed ID: 25260861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK; Peters TJ; Taylor NF; Wood PJ; Wessely S; Cleare AJ
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ
    Trends Endocrinol Metab; 2004 Mar; 15(2):55-9. PubMed ID: 15036250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ; O'Keane V; Miell JP
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Van Houdenhove B; Cosyns P; Claes SJ
    Neuropsychobiology; 2007; 55(2):112-20. PubMed ID: 17596739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome.
    Nater UM; Youngblood LS; Jones JF; Unger ER; Miller AH; Reeves WC; Heim C
    Psychosom Med; 2008 Apr; 70(3):298-305. PubMed ID: 18378875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.